Literature DB >> 16482478

[Structures of acute rheumatic care].

M Stier-Jarmer1, W Liman, G Stucki, J Braun.   

Abstract

Severe rheumatological systemic diseases demand high levels of diagnostic and therapeutic measures and differentiated and complex methods of care. In Germany, specialised rheumatologists and, if hospitalisation is indicated, specialised rheumatology hospitals or departments are responsible for the treatment of these patients. Early rehabilitation procedures, provided by a multidisciplinary therapeutic team, are an important component of the treatment concept in these facilities. Early rehabilitation is integrated into the patients acute medical treatment plan, with careful consideration of the patients current health problems and functional capabilities (body functions and structures, activities and participation as outlined in the ICF), thereby providing a comprehensive, integrated therapy strategy which has long been acknowledged as necessary for the successful treatment of rheumatoid patients. This article presents an analysis concerning the development, organisation, facilities and processes of the acute medical in-patient care for patients with rheumatological disorders in Germany. In total there are 4188 beds in 88 acute hospitals exclusively available for rheumatological in-patients in Germany at present. There is at least one facility specialised in rheumatology in every German federal state. The density of care in the German federal states varies between 131.8 beds per 1 million inhabitants in Bremen and 9 beds per 1 million inhabitants in Saxony. In most regions of Germany the acute in-patient care for patients with rheumatological disorders is provided by hospitals specialised in rheumatology. Rheumatological patients are treated in a variety of hospital departments. In the year 2000 only 47% of the inpatients with rheumatoid arthritis, 56% of those with ankylosing spondylitis and 28% of those with systemic lupus erythematosus were treated in a ward specialising in rheumatology. Rheumatoid arthritis, with a total share of nearly 30%, was the most frequently treated rheumatic disease in wards specialising in rheumatology, followed by soft tissue disorders (e.g. fibromyalgia), diseases with systemic involvement of connective tissue and inflammatory spinal disorders such as ankylosing spondylitis.

Entities:  

Mesh:

Year:  2006        PMID: 16482478     DOI: 10.1007/s00393-005-0015-2

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  31 in total

1.  Employment perspectives of patients with ankylosing spondylitis.

Authors:  A M J Chorus; A Boonen; H S Miedema; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

2.  [Memorandum on the position and development of rehabilitation for patients with rheumatic diseases].

Authors:  W H Jäckel; W F Beyer; U Droste; M Engel; E Genth; H G Pott; K L Schmidt
Journal:  Z Rheumatol       Date:  1996 Nov-Dec       Impact factor: 1.372

3.  [Aspects of quality assurance in a rheumatology clinic. A contribution to the problem of length of stay and unnecessary admission].

Authors:  K L Schmidt
Journal:  Z Arztl Fortbild Qualitatssich       Date:  1998-03

4.  [Principles of continuous and cooperative community management of chronic rheumatoid patients in Germany. Committee for Regional Rheumatologic Management].

Authors: 
Journal:  Z Rheumatol       Date:  1994 May-Jun       Impact factor: 1.372

5.  [Long-term follow-up and prognosis of work capacity in the early stage of chronic polyarthritis].

Authors:  W Bräuer; S Merkesdal; W Mau
Journal:  Z Rheumatol       Date:  2002-08       Impact factor: 1.372

6.  Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.

Authors:  A Boonen; D van der Heijde; R Landewé; A Spoorenberg; H Schouten; M Rutten-van Mölken; F Guillemin; M Dougados; H Mielants; K de Vlam; H van der Tempel; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

Review 7.  [Value of inpatient care in rheumatoid arthritis-an evidence based report].

Authors:  M Schneider; M Lelgemann; C Baerwald; J Braun; M Hammer; P Kern; A Krause; R Alten; U Faubel; M Hammer; J Lakomek; W Liman; Th Pauly; A Schnabel
Journal:  Z Rheumatol       Date:  2004-10       Impact factor: 1.372

8.  A randomized clinical trial of in-patient multidisciplinary treatment versus routine out-patient care in active rheumatoid arthritis.

Authors:  T P Vliet Vlieland; A H Zwinderman; J P Vandenbroucke; F C Breedveld; J M Hazes
Journal:  Br J Rheumatol       Date:  1996-05

9.  Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey.

Authors:  Elina Savolainen; Oili Kaipiainen-Seppänen; Liisa Kröger; Riitta Luosujärvi
Journal:  J Rheumatol       Date:  2003-11       Impact factor: 4.666

Review 10.  Biological therapies in the spondyloarthritides--the current state.

Authors:  J Braun; J Sieper
Journal:  Rheumatology (Oxford)       Date:  2004-06-08       Impact factor: 7.580

View more
  2 in total

1.  [International classification of functioning, disability and health and its significance for rheumatology].

Authors:  J Braun; J Zochling; E Grill; W Liman; G Stucki
Journal:  Z Rheumatol       Date:  2007-11       Impact factor: 1.372

2.  [§ 116b SGB V (social insurance code, book five) for rheumatology patients. An empirical assessment on the basis of administrative data].

Authors:  T Rath; E Bokern; E Sefo-Bukow; G Büscher; M Lüngen; A Rubbert-Roth
Journal:  Z Rheumatol       Date:  2011-01       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.